Targeting the ATM pathway for the treatment of CLL

Tatjana Stankovic, MD, PhD, University of Birmingham, Birmingham, UK discusses recent findings in the ataxia-telangiectasia mutated (ATM) pathway including targeting this pathway in Chronic Lymphocytic Leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

• Kategorie